Ameile

Ameile Uses, Dosage, Side Effects, Food Interaction and all others data.

Ameile is a third-generation EGFR tyrosine kinase inhibitor targeting EGFR-sensitizing and T790M resistance mutations. It is being investigated against advanced or metastatic EGFR-mutated non-small cell lung cancer (NSCLC).

Trade Name Ameile
Generic Almonertinib
Almonertinib Other Names Almonertinib, HS-10296
Type
Formula C30H35N7O2
Weight Average: 525.657
Monoisotopic: 525.285223395
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Ameile
Ameile

How Ameile works

Ameile inhibits EGFR tyrosine kinase targeting EGFR-sensitizing and T790M resistance mutations.

Innovators Monograph

You find simplified version here Ameile

*** Taking medicines without doctor's advice can cause long-term problems.
Share